Applying a gel to internal tissues of animals after cardiac surgery significantly limits the formation of adhesions, a problematic form of scar tissue, Stanford researchers have found.

Stanford researchers have identified immune cells that help reduce the severity of a disease in mice akin to multiple sclerosis. These cells could one day be useful therapeutic targets in treating autoimmune diseases.

When surveyors from The Joint Commission conducted their triennial accreditation survey earlier this summer, Stanford Health Care passed with flying colors.

A large multicenter clinical trial led by Stanford physician Tait Shanafelt, MD, indicates that people with chronic lymphocytic leukemia may forgo chemotherapy in favor of new, targeted treatments.

Cancer cells are known to protect themselves using proteins that tell immune cells not to attack them. Stanford researchers have discovered a new “don’t eat me” signal, and blocking it may make cancer cells vulnerable to attack by the immune system.

With the grant renewal, Stanford will continue to collaborate with a national network of medical research institutions on sharing resources and improving the processes that enable research discoveries to become medical treatments and cures.

Stanford researchers identified a gene crucial to the formation of toxic proteins in amyotrophic lateral sclerosis and showed how it could inform potential therapies for the disease.

Stanford scientists and their collaborators have discovered the protective role played by identity-morphing cells — and the gene behind them — in atherosclerosis, according to a new study.

In a large trial led by a Stanford investigator, an experimental drug produced clinically meaningful improvements for rheumatoid arthritis patients unresponsive to existing treatments.

Christian Guilleminault, a prolific researcher who helped build Stanford’s sleep disorders clinic into an influential, full-service sleep center, died July 9 of cancer.